Moderna Inc. (MRNA)
NASDAQ: MRNA
· Real-Time Price · USD
27.19
0.97 (3.70%)
At close: Aug 22, 2025, 1:40 PM
3.70% (1D)
| Bid | 26.11 |
| Market Cap | 10.58B |
| Revenue (ttm) | 3.06B |
| Net Income (ttm) | -2.9B |
| EPS (ttm) | -7.51 |
| PE Ratio (ttm) | -3.62 |
| Forward PE | -3.59 |
| Analyst | Hold |
| Ask | 28.85 |
| Volume | 6,199,326 |
| Avg. Volume (20D) | 9,403,548 |
| Open | 26.40 |
| Previous Close | 26.22 |
| Day's Range | 26.38 - 27.80 |
| 52-Week Range | 23.15 - 84.28 |
| Beta | 1.83 |
About MRNA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MRNA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MRNA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Moderna Inc. is scheduled to release its earnings on
Nov 6, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 hours ago
Moderna shares are trading higher after the compan...
Unlock content with
Pro Subscription
2 weeks ago
-2.77%
Moderna shares are trading lower after HHS said it will cancel 22 vaccine development projects totaling $500 million.
